All Stories

  1. Genomic Sequencing: Assessing The Health Care System, Policy, And Big-Data Implications
  2. The economic value of personalized medicine tests: what we know and what we need to know
  3. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case ofHER2/Neutesting in breast cancer
  4. Company Profile: Center for Business Models in Healthcare
  5. Barriers to the Use of Personalized Medicine in Breast Cancer
  6. Abstract A38: Are breast cancer screening patients with family cancer history directed to genetic counseling/testing?
  7. Health Technology Assessment and Private Payers' Coverage of Personalized Medicine
  8. The impact of BRCA testing on surgical treatment decisions for patients with breast cancer
  9. Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay
  10. Capacity building for assessing new technologies: approaches to examining personalized medicine in practice
  11. PHP85 WHEN AND HOW ARE EVIDENCE REVIEWS ON PERSONALIZED MEDICINE USED FOR HEALTH PLAN POLICY DECISIONS?